Memorandum from NZSG
Posted Thursday April 6, 2023
The NZSG Working Group for IBD Medication after discussion with NZSG members, Pharmac and pharmaceutical company representatives have written an e-guidance document on ustenkinumab treatment and ongoing maintenance doses. Please find this on the NZSG website.
Gallery
Related Articles
2025 Advanced Gastroenterology Training Opportunities (Match 2024) Information
Tuesday April 2, 2024
NZSG will be accepting applications for placements from the 8th of April 2024. The final date for applying is Friday the...
Thank you from NZSG to our many Annual Scientific Meeting Sponsors
Tuesday March 26, 2024
The NZSG-NZgNC Annual Scientific Meeting 2023 held in Rotorua on 6 to 8 December was made possible with the support of o...
NZSG-Janssen Research Fellowship
Tuesday March 26, 2024
The Fellowship providing much needed gastroenterology research funding is 10 years old!